EPA (Omega 3 Fatty Acid) Useful Add-on Therapy in Schizophrenia

Schizophrenia Update

By: Laurie Barclay, MD

Sept. 9, 2002 — Ethyl-eicosapentaenoic acid (EPA) may be a useful add-on therapy for schizophrenia, according to results of a randomized, placebo-controlled trial published in the September issue of the American Journal of Psychiatry. Patients who were still symptomatic after six months of standard therapy had a significant reduction in both positive and negative symptoms after 12 weeks of treatment.

"Extrapyramidal symp>Early Schizophrenia Screening Test

An Introduction to Schizophrenia

General Schizophrenia Information



   Copyright 1996-2004. All Rights Reserved. ODY>